InnovAge Holding (INNV) risk factors, FY2024 10-K

Risks Related to Our Business

1. 01Our growth strategy may not prove viable, and we may not realize expected results therefrom
2. 02are unsuccessful in hiring, training, managing and integrating these new employees, if we are not successful in retaining our existing employees, or if we are unable to provide the care and services that our participants require in compliance with regulatory requirements, our business will be adversely affected
3. 03Our growth strategy is partially dependent upon our ability to identify and successfully complete acquisitions, joint ventures and other strategic partnerships
4. 04If we are unable to attract new participants and retain existing participants, our revenue growth will be adversely affected
5. 05competitors, we may not be able to effectively implement our growth strategy, which depends on our ability to attract new participants
6. 06Our overall business results have been and we expect will continue to be impacted by ongoing macroeconomic and industry-related challenges, including labor shortages, labor competition and inflation
7. 07We are subject to legal proceedings, enforcement actions and litigation, malpractice and privacy disputes, which are costly to defend and could materially harm our business and results of operations
8. 08Under our PACE contracts, we assume all of the risk that the cost of providing services will exceed our compensation
9. 09We have experienced and expect to continue experiencing increased costs and expenditures in the future
10. 10Our revenues and operations are dependent upon a limited number of government payors, particularly Medicare and Medicaid
11. 11Reductions in PACE reimbursement rates or changes in the rules governing PACE programs could have a material adverse effect on our financial condition and results of operations
12. 12Our records and submissions to government payors may contain inaccurate or unsupportable information regarding risk adjustment scores of participants, which could cause us to overstate or understate our revenue and subject us to repayment obligations or penalties
13. 13Renegotiation, non-renewal or termination of capitation agreements with government payors could have a material adverse effect on our business, results of operations, financial condition and cash flows
14. 14State and federal efforts to reduce healthcare spending could adversely affect our financial condition and results of operations
15. 15We depend on our senior management team and other key employees, and the loss of one or more of these employees or an inability to attract and retain other highly skilled employees could harm our business
16. 16Labor relations matters could have a material adverse effect on our business, reputation, prospects, results of operations and financial condition
17. 17If certain of our suppliers do not meet our needs, if we are not reimbursed or adequately reimbursed for medical products we purchase or if we are unable to effectively access new technology or medical products, our ability to effectively provide the services we offer could be negatively impacted
18. 18We conduct a significant percentage of our operations in the State of Colorado and, as a result, we are particularly susceptible to regulatory issues and reduction in budget appropriations for our services or any other adverse developments in that state
19. 19If we fail to manage our operations effectively, we may be unable to execute our business plan, maintain effective levels of service and participant satisfaction or adequately address competitive challenges
20. 20The healthcare industry is highly competitive and, if we are not able to compete effectively, our business could be harmed
21. 21Our presence is currently limited to Colorado, California, Florida, New Mexico, Pennsylvania and Virginia, and we may not be able to successfully establish a presence in new geographic markets
22. 22Security breaches, loss of data and other disruptions have in the past and could in the future compromise sensitive information related to our business or our participants, or prevent us from accessing critical information and expose us to liability, and could adversely affect our business and our reputation
23. 23repair or replace systems or technology and to prevent future occurrences. We may also be subject to potential increases in insurance premiums, resulting in increased costs or loss of revenue
24. 24A failure to accurately estimate incurred but not reported medical expenses could adversely affect our results of operations
25. 25We lease half of our centers and may experience risks relating to lease termination, lease expense escalators, lease extensions and special charges
26. 26A pandemic, epidemic or outbreak of an infectious disease in the United States or worldwide, such as COVID-19, as well as weather and other factors, have affected, and could in the future adversely affect our business

Risks Related to Regulation

1. 27Allegations that we have failed to adhere to all of the complex government laws and regulations that apply to our business have had and could in the future have a material adverse effect on our business, results of operations, financial condition, cash flows, reputation and stock price
2. 28Federal and state manuals, policies, and other guidance may also affect our operations
3. 29In addition to the provisions of the FCA, the federal government can use several criminal statutes to prosecute persons who are alleged to have submitted false or fraudulent claims for payment to the federal government
4. 30If we are unable to effectively adapt to changes in the healthcare industry, including changes to laws and regulations regarding or affecting U.S. healthcare reform, our business could be harmed
5. 31Laws regulating the corporate practice of medicine could restrict the manner in which we are permitted to conduct our business, and the failure to comply with such laws could subject us to penalties or require a restructuring of our business
6. 32Laws governing the review and approval of healthcare transactions could limit our ability to grow our business

Risks Related to Our Indebtedness

1. 33Our existing indebtedness could adversely affect our business and growth prospects
2. 34Our failure to raise additional capital or generate cash flows necessary to expand our operations and invest in participant services in the future could reduce our ability to compete successfully and harm our results of operations

Risks Related to Our Common Stock

1. 35Our Principal Shareholders control us, and their interests may conflict with ours or yours in the future
2. 36We qualify as an “emerging growth company” and a “smaller reporting company” and we have elected to comply with reduced public company reporting requirements, which could make our common stock less attractive to investors
3. 37Provisions of our corporate governance documents could make an acquisition of us more difficult and may prevent attempts by our shareholders to replace or remove our current management, even if beneficial to our shareholders
4. 38exclusive forum for litigation arising under the Securities Act, which could limit our shareholders’ ability to obtain a favorable judicial forum for disputes with us
5. 39Our operating results have fluctuated and may fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause such results to fall below any guidance, targets or goals we provide
6. 40Our operating results and stock price are volatile
7. 41Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock
8. 42Because we have no plans to pay regular cash dividends on our common stock for the foreseeable future, you may not receive any return on investment unless you sell your common stock for a price greater than that which you paid for it
9. 43Our Board of Directors has approved a share repurchase program that may subject us to certain risks, which can be exacerbated because our stock is thinly traded
10. 44If securities or industry analysts do not publish research or reports about our business, if they adversely change their recommendations regarding our shares or if our results of operations do not meet their expectations, our stock price and trading volume could decline
11. 45We may issue shares of preferred stock in the future, which could make it difficult for another company to acquire us or could otherwise adversely affect holders of our common stock, which could depress the price of our common stock
12. 46Future offerings of debt or equity securities by us may materially adversely affect the market price of our common stock
13. 47Disruptions in our disaster recovery systems or business continuity planning could limit our ability to operate our business effectively